The recombinant avirulent Newcastle disease virus (NDV) LaSota strain expressing the rabies virus glycoprotein (rL-RVG) can induce much greater apoptosis than can NDV in gastric carcinoma cells, but the mechanisms involved remains unclear.
Background
Cancer is the second leading cause of human mortality worldwide [1, 2] and stomach cancer is one of the main causes of cancer-related mortality [1] . Many studies have demonstrated that biological treatment, including oncolytic virotherapy, has great potential for the treatment of cancer [3, 4] . Newcastle disease virus (NDV) is an avian paramyxovirus that can spread from birds to humans, but the pathogenicity in humans is minimal, limited to mild flulike symptoms and conjunctivitis [5] . A lentogenic strain of this virus has demonstrated selective cytopathic efficacy against cancer cells [6] . NDV has been explored as an oncolytic agent [7, 8] . Acetylcholine receptors (AChR) are highly expressed in non-small cell lung cancer, gastric cancer, bladder cancer, and colorectal cancer [9] . Many studies have found that a7-nAChR affects expression and activation of cancer cell proliferation, invasion, metastasis, angiogenesis, and the inflammatory response [10] [11] [12] . The rabies virus glycoprotein has a nicotine receptor blocking function similar to that of coral snake venom [13] . We have previously reported that rL-RVG [14] can induce greater autophagy and apoptosis in gastric carcinoma cells than can NDV [15] . In this investigation, we focused on the molecular mechanisms of apoptosis in gastric carcinoma HGC or SGC cells treated with rL-RVG through inhibition of the phosphoinositide 3-kinase/protein kinase B (PI3K/AKT) signaling pathway.
Material and Methods

Materials
EDTA-2Na, 1640, and trypsin were from Gibco (NY, USA). Fetal bovine serum (FBS) was supplied by Hyclone (UT, USA). The human cancer cell lines SGC-7901 and HGC were purchased from the Cancer Cell Repository (Shanghai Cell Bank, 2010-02-20). rL-RVG and NDV were kindly provided by Harbin Veterinary Research Institute (Harbin, Heilongjiang, China). a7-nAChR antagonist methyl lycaconitine citrate hydrate (MLA): sc-253043 was obtained from Santa Cruz (CA, USA), a7-nAChR agonist acetylcholine bromide (ACB) was from Sigma (USA), AKT antagonist MK-2206 was purchased from Merck (Darmstadt, Germany), AKT agonist IGF-1 was from Abcam (USA), and Hoechst 33342 was purchased from Sigma-Aldrich (St. Louis, MO, USA). Rabbit polyclonal anti-Bax and anti-Bcl-2 were from Boster (Wuhan, Hubei, China). Rabbit monoclonal anti-p-AKT antibody and anti-PI3K antibody were from Cell Signaling Technology (Beverly, MA, USA), Anti-cleaved-caspase-3 was from ImmunoWay (Newark, DE, USA). Horseradish peroxidase (HRP)-conjugated goat anti-rabbit, HRP-conjugated goat anti-mouse, and FITC-conjugated goat anti-mouse antibodies were purchased from CWBio (Shanghai, China). Cy3-conjugated goat anti-rabbit antibody was purchased from KPL (Washington, DC, USA), and TUNEL assay kits were from Nanjin (China). A short interfering (si) RNA specific for human a7-nAChR was obtained from GenePharma (Shanghai, China).
Cell culture
SGC and HGC cells were cultured in RPMI 1640 medium with 10% (v/v) fetal bovine serum at 37°C with 5% CO 2 and 100% humidity. After growing to 50-70% confluence in 6-well plates, the SGC and HGC cells were treated with rL-RVG, NDV, or phosphate-buffered saline (PBS).
MTT assay
SGC or HGC cell suspensions (1×10 4 ) were transferred into 96-well plates and continued to culture in 10% FBS at 37°C with 5% CO 2 for 24 h. The next day, the cells were infected with rL-RVG (10 9.8 EID50/ml) or NDV (10 9.8 EID50/ml) [14] , or 10 5 times. After 1 h, the cells were cultured as described previously and divided into an rL-RVG group, an NDV group, or a PBS blank control group and then each well was treated with 20 μl MTT (5 mg/ml, PBS) and continued to culture for 4 h on the third day. After that, we added 150 μl of DMSO into each well for 10 min. Lastly, a standard spectrophotometer was used to measure the absorbance in triplicate. The morphological changes of infected cells were assessed under a light microscope.
Interference test with agonist or antagonist or siRNA a7-nAChR antagonist MLA or agonist ACB was also applied. When the SGC and HGC cells had grown to 50-70% confluence in the 6-well plates, the cells were pretreated with 10 -3 mmol/L MLA or ACB [16] . Furthermore, the AKT antagonist MK-2206 or agonist IGF-1 was pretreated as described above, and 12 h later, the cells were treated with rL-RVG, NDV, or PBS for 24 h [2] . Finally, the cells were extracted and analyzed by immunofluorescence and Western blot analysis. Moreover, the siRNA for a7-nAChR was also applied, and the HGC cells were pretreated with si-a7-nAChR (50 nM) following the manufacturer's instructions. The next day, the cells were infected with rL-RVG or NDV for 24 h and then analyzed by Western blot.
Immunofluorescence assay
Cells in logarithmic growth phase were infected with rL-RVG, NDV, or PBS for 24 h and then fixed in 4% paraformaldehyde at 4°C overnight, followed by immunofluorescence staining with antibodies against a7-nAChR and Hoechst 33342 staining. lmmunofluorescence microscopy was used to observed the stained SGC and HGC cells.
Western blot assay
RIPA lysis buffer with a protease antagonist cocktail was used to lyse SGC and HGC cells with or without treatment. BCA kits were used to assess protein concentrations. After separating by electrophoresis, the proteins were transferred to a polyvinylidene difluoride (PVDF) membrane. Next, the membrane was blocked with 5% BSA for 1 h. Then, the membrane was incubated with primary antibodies against specific proteins (NDV and RVG for infection; cleaved caspases 3, Bcl-2, and Bax; a7-nAChR, PI3K, and p-AKT for a7-nAChR/PI3K/p-AKT pathway), and then continued to be treated by HRP-conjugated secondary rabbit or mouse antibodies. Finally, the proteins were detected and analyzed by using Pierce ECL Plus Substrate under a Typhoon9400 Variable Mode Imager.
Flow cytometry assay
Apoptotic and viable cells were analyzed with flow cytometry (FCM) and annexin V/propidium iodide (PI) double-staining to detect membrane events. FCM analysis of the labeled cells was performed by FACSort flow cytometry, and the data were analyzed with CellQuest software. The cytograms of the 4 quadrants were used to differentiate normal (annexin V2-/PI-), early apoptotic (annexin V+/PI-), late apoptotic (annexin V+/PI+), and necrotic (annexin V2-/PI+) cells. Apoptosis was calculated as the total numbers of early and late apoptotic cells. All experiments were carried out in triplicate.
TUNEL assay
In interference testing, the HGC cells were pretreated with a7-nAChR inhibitor MLA (10 -3 mol/L) or a7-nAChR agonist ACB (10 -3 mol/L) 4 h before infection with NDV or rL-RVG (10 MOI). Annexin V/PI staining was performed to detect apoptosis/necrosis, and 12 h later, treated by the diluted rL-RVG or wild-type NDV at an MOI of 10, with PBS as negative control. TUNEL assay kits were used according to the manufacturer's instructions. At 24 h after infection, ice-cold 4% paraformaldehyde (Solar Biotech, Beijing, China) was used to fix the cells for 30 min at room temperature, then, the cells were washed with PBS and continued to incubated with 3% hydrogen peroxide in methanol at room temperature for 10 min. After being rinsed with PBS, the samples were incubated with 0.1% Triton X-100 and 0.1% sodium citrate in water at room temperature for 30 min. The pretreated specimens were treated with 50 μL of TdTlabeled reaction buffer at 4°C overnight in the dark and then in a humidified atmosphere at 37°C for an additional 2-3 h. Subsequently, the slides were incubated with 50 μL of streptavidin-HRP for 60 min, followed by detection with 50 μL of diaminobenzidine reagent for 10 min. Finally, the cells were observed and imaged under an optical microscope (ECLIPSE TS100, Nikon, Japan). This process was repeated 3 times.
Statistical analysis
All data and results were presented as the mean ± standard deviation and were analyzed by SPSS 19.0 software (IBM Corp., Armonk, NY). One-way analysis of variance (ANOVA) was used to analyze the statistical significance, and then post hoc analysis was performed to compare the differences between multiple groups. P<0.05 was a statistically significant difference. All experiments were repeated at least 3 times.
Results
Protein expression of NDV and RVG proteins after infection with rL-RVG and NDV
Western blot analysis revealed that HGC and SGC cells expressed the NDV HN protein after infection with NDV, and they also expressed NDV protein and RVG protein after infection with rL-RVG, while the NDV HN and RVG proteins were expressed at very low levels in the PBS group. Compared with the NDV group, RVG and NDV protein expression was higher in the rL-RVG group (P<0.05), as shown in Figure 1 .
The changes in SGC and HGC cell proliferation after infection with rL-RVG and NDV
After infection with rL-RVG and NDV, cell viability of SGC and HGC were detected and analyzed by MTT assay. Cell viability of SGC and HGC cells increased with decreased virus concentration, and, compared with the control group, the dose-response curve reached a plateau at the 10 3 dilution. The OD of MTT in the rL-RVG group was weaker than in the NDV-infected group, which suggested that rL-RVG had a stronger inhibitory ability. The results are shown in Figure 2 .
Effects of rL-RVG on the protein expression of a7-nAChR
Western blot analysis showed that when the SGC and HGC cells were infected with rL-RVG or NDV, the protein expression of a7-nAChR in the rL-RVG group was obviously higher than in the NDV group and PBS group (P<0.01). Moreover, the a7-nAChR protein expression in immunofluorescence had the same trend, as shown in Figures 1 and 3 .
Effects of rL-RVG, a7-nAChR agonist, or antagonist pretreatment on morphological changes and the apoptosis in HGC cells Protein expression of RVG was only detected in the rL-RVG group (** P<0.01), while protein expression of NDV was higher in the rL-RVG and NDV groups compared with the PBS groups (** P<0.01). The expression level of cleaved caspase 3 in the rL-RVG group was higher than that in the NDV group or PBS group (** P<0.01). The expression level of a7-nAChR in the rL-RVG group was higher than in the other groups (** p<0.01). 
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the rL-RVG-infected groups. When groups were treated by a7-nAChR antagonist MLA, the HGC cell morphological changes were much more obvious, including cell membrane shriveling and suspended growth, but the rL-RVG+MLA group cells showed little change. While the NDV group and PBS group were treated by MLA, the state of suspended growth and cell membrane shrivel appeared much more obvious compared with the rL-RVG group. When groups were treated by a7-nAChR agonist ACB, the HGC cell morphological changes trended to survive, but the morphological changes had no difference between the PBS +ACB group and the control group, as shown in Figure 4A .
TUNEL assay indicated that the apoptosis level of rL-RVGinfected HGC cells was higher than in the NDV group or PBS group, and there were more apoptotic cells in the rL-RVG group than in the NDV-infected group. When the rL-RVG groups were pretreated by a7-nAChR antagonist MLA or a7-nAChR agonist ACB, we found little difference between the rL-RVG groups and the rL-RVG+MLA group, but there were fewer apoptotic cells in the rL-RVG+ACB group than in the rL-RVG group. On the other hand, the NDV and PBS pretreatment groups with MLA had more apoptotic cells than in the NDV and PBS groups. The numbers of apoptotic cells in the NDV group and the PBS group decreased after being pretreated with ACB, as shown in Figure 4B . When FCM analysis was used to detected the apoptosis of cells with interference, Annexin V staining showed that pretreatment with a7-nAChR agonist ACB led to a significant decrease in apoptosis, but pretreatment with a7-nAChR inhibitor MLA led to an obvious increase in apoptosis, except in the rL-RVG+MLA group and the rL-RVG group. The results were in agreement with the Western blot results, as shown in Figure 4C .
Effects of a7-nAChR agonist or antagonist and siRNA pretreatment on the expression of a7-nAChR and apoptosis-related proteins
We chose the HGC cell line for antagonist and agonist treatment study. The a7-nAChR antagonist MLA was used to pretreat the gastric carcinoma HGC cells before cells were infected with rL-RVG or NDV. a7-nAChR protein expression decreased significantly (P<0.01) in NDV and PBS groups pretreated with MLA, but the difference between the rL-RVG group and rL-RVG+MLA group was not significant (P>0.05), as shown in Figure 5A . When the a7-nAChR agonist ACB was used to pretreat HGC cells before being infected with rL-RVG or NDV, the a7-nAChR protein expression increased significantly (P<0.05) in ACB-pretreated groups, as shown in Figure 5B . Furthermore, when a7-nAChR siRNA was used to pretreat the gastric carcinoma HGC cells before being infected with virus rL-RVG or NDV, the a7-nAChR protein expression decreased significantly (P<0.01) in the a7-nAChR siRNA-pretreated groups, as shown in Figure 5C . When groups were treated by a7-nAChR antagonist MLA, the morphological changes in HGC cells were clearly more pronounced, including cell membrane shriveling and suspended growth, but the rL-RVG+MLA group showed little change. When groups were treated with a7-nAChR agonist ACB, the HGC cell morphological changes trended to persist, but there was no significant difference in morphological changes between the PBS+ACB group and the control group in comparison with the rL-RVG group. (B) TUNEL assay was used to assess apoptosis of infected HGC cells. (C) There were more apoptotic cells in the rL-RVG group than in the NDV group or PBS group (** P<0.01). When groups were treated with the a7-nAChR antagonist MLA, the apoptotic cells were more abundant than in the groups without pretreatment (P<0.01), except for the rL-RVG+MLA group and the rL-RVG group (P>0.05). When the a7-nAChR agonist ACB cells were pretreated before virus infection, the number of apoptotic cells decreased (** P<0.01), including early apoptotic (annexin V+/PI-) and late apoptotic (annexin V+/PI+) cells. * P<0.05.
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The SGC and HGC cells was assessed by Western blot analysis at 24 h after being infected with NDV or rL-RVG. Western blot assay showed the expression levels of cleaved caspase 3 proteins in the rL-RVG-infected groups were higher than in the NDV and PBS groups, as shown in Figure 1 . We chose HGC cells for further study. When the groups were treated with a7-nAChR antagonist MLA or a7-nAChR siRNA, the expression level of apoptosis-related proteins cleaved caspases 3 and Bax/Bcl-2 increased significantly (P<0.05) in the pretreated NDV and pretreated PBS groups, but the difference between the rL-RVG and pretreated groups was insignificant (P>0.05), as shown in Figure 5A and 5C. When the virus induced apoptosis in HGC cells after pretreating with a7-nAChR agonist ACB, the levels of the apoptosis-related proteins cleaved caspases 3 and Bax/Bcl-2 decreased significantly (P<0.05), as shown in Figure 5B . Effects of rL-RVG, a7-nAChR agonist, and antagonist and siRNA pretreatment on the expression of PI3K/p-AKT pathway proteins in HGC cells HGC cells was assessed routinely by Western blot analysis at 24 h after being infected with NDV or rL-RVG. The expression of PI3K and p-AKT proteins in the rL-RVG-infected groups were higher than in the NDV or PBS groups, as shown in Figure 5A -5C. When the groups were treated with a7-nAChR antagonist or a7-nAChR siRNA, the expression of PI3K and p-AKT proteins decreased significantly (P<0.05), but the differences between the rL-RVG group and the pretreatment-rL-RVG group were not obvious, as shown in Figure 5A and 5C. However, in the HGC cells infected with rL-RVG or NDV after pretreatment with a7-nAChR agonist, the levels of PI3K and p-AKT increased significantly (P<0.05), as shown in Figure 5B .
Effects of AKT antagonist or agonist on the expression of PI3K or p-AKT proteins and the apoptosis-associated proteins in gastric cancer HCG cells When HGC cells were pretreated with AKT antagonist MK-2206, the expression of PI3K and p-AKT proteins and apoptosis-related proteins cleaved caspases 3 and Bax/Bcl-2 decreased significantly (P<0.05) in the NDV or PBS groups, but there was no insignificant difference between the rL-RVG and pretreated groups (P>0.05), as shown in Figure 6A . When the HGC cells were pretreated with AKT agonist IGF-1 before infection with NDV or rL-RVG, the expression levels of the apoptosis-related proteins cleaved caspases 3 and Bax/Bcl-2 increased significantly (P<0.05), as shown in Figure 6B .
Discussion
NDV is an oncolytic agent with obvious efficacy extensively demonstrated in both preclinical and clinical studies [17, 18] . It has been reported that rL-RVG spreads more easily and has much higher antitumor potency [2] . Multiple mechanisms underly NDV-induced cytotoxicity, such as immunomodulatory mechanisms [19] [20] [21] , autophagy pathways [22, 23] , and apoptotic pathways [24] . But the mechanisms by which rL-RVG exerts greater apoptosis than NDV are not completely clear. Our study demonstrates that the a7-nAChR is antagonized and the PI3K/p-AKT pathway is inhibited, and then promotes apoptosis in gastric carcinoma cells infected with rL-RVG. It is found that nicotine promotes gastric cancer cell proliferation and metastasis related to a7-nAChR [25] . a7-nAChR antagonists of a-coral snake toxins (a-BTX) and a-cyclophosphamide can reduce the effect on promoting proliferation of nicotine [26] . a7-nAChR pathway activation promotes tumor cell proliferation and inhibits apoptosis via PI3K/AKT signaling pathways [27] . Recent studies suggest that some chemotherapeutic drugs, including 5-Fluorouracil and Ixabepilone, can downregulated a7-nAChR and promote gastric cancer cell apoptosis through the AKT pathway [28, 29] . The rabies virus glycoprotein has nicotine receptor blocking function similar to that of coral snake venom [10] .
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When gastric cancer cells were infected by the rL-RVG, the stable expression of RVG protein indicated that rL-RVG infected the SGC and HGC cells successfully. The expression of the a7-nAChR protein was upregulated in the rL-RVG group and a7-nAChR is beneficial to cell survival [25, 28, 29] . In our study, we found the expression of cleaved caspase 3 in the rL-RVG group was higher than in the NDV or PBS groups, and the rL-RVG group had many more apoptotic cells than in the NDV group. In contrast, there was a higher level a7-nAChR expression in the rL-RVG group, suggesting that the rabies virus glucoprotein (RVG) produced in the rL-RVG group could combine and inhibit a7-nAChR competitively in the rL-RVG-infected gastric cancer cells, which led to increased a7-nAChR expression via negative feedback. When the a7-nAChR antagonist MAL was pretreated, the expression level of the a7-nAChR apoptosis-related proteins significantly increased. In contrast, when the a7-nAChR agonist ACB was pretreated, the level expression of the a7-nAChR protein increased and the level of apoptosisrelated proteins decreased, which suggested the a7-nAChR agonist ACB can activate nAChR and inhibit apoptosis [30] . It appears that the mechanism by which rL-RVG promotes gastric cancer cell apoptosis involves antagonizing a7-nAChR.
a7-nAChR agonist can induce Bcl-2 phosphorylation to inhibit apoptosis [31] . In the present study, a7-nAChR antagonist MLA and rL-RVG downregulated the expression of the Bcl-2, p-AKT, and PI3K, and there was a stronger decrease in the rL-RVG group. However, when HGC cells were pretreated with a7-nAChR agonist ACB, the levels of Bcl-2, p-AKT, and PI3K expression increased significantly, which suggested rL-RVG antagonizes a7-nAChR and inhibits the PI3K/AKT pathway and then inhibits the bcl-2 pathway. Activation of the PI3K/AKT pathway can lead to Bax Ser184 residue phosphorylation and inactivation, thus inhibiting apoptosis [32] . Activation of AKT can inhibit mitochondrial release cytochrome and apoptosis factor to inhibit cell apoptosis [33] . In our study, rL-RVG promoted HGC cell apoptosis by inhibiting expression of the PI3K/ AKT pathway-related proteins. When HGC cells was pretreated with the AKT antagonist MK-2206, the expression of Bcl-2, p-AKT, and PI3K were strongly decreased. In contrast, when the AKT agonist IGF-1 was used in advance, the expression of the Bcl-2, p-AKT, and PI3K strongly increased and the expression of Bax and cleaved caspase 3 strongly decreased. These results indicate rL-RVG inhibits PI3K/p-AKT by the a7-nAChR pathway. In addition, ERK and AKT pathways are overactive in NDV-infected RPMI-7951 cells [34] , and NDV transiently activates the PI3K/AKT pathway in chicken cells at an early phase of infection [35] . In the present study, we also found that the expression of PI3K and AKT in the NDV group was sometimes increased compared with the PBS group.
Conclusions
In conclusion, this study shows that the a7-nAChR/PI3K/AKT signaling pathway participates in the effect of rL-RVG on SGC and HGC cells. Furthermore, rL-RVG can promote apoptosis through activating Bax and Caspase 3 signaling pathways.
In addition, rL-RVG antagonized a7-nAChR, which promoted the PI3K/p-AKT pathway [27] , and inhibited the survival of gastric cancer cells, suggesting that the a7-nAChR/PI3K/AKT pathway played an important role in rL-RVG virus-induced apoptosis. Our research demonstrates that rL-RVG promotes apoptosis by antagonizing a7-nAChR and the inhibiting PI3K/AKT pathway in gastric carcinoma cells. Our results support the great advantages of rL-RVG in biological treatment of gastric cancer.
